In this episode of Denatured, you’ll hear from Christina Takke, managing partner at V-Bio Ventures and Mariette van der Velden-Roesink, founding partner at Curie Capital. We explore why the Benelux region remains scientifically strong, but investment fragmented, and what it will take to turn it into a more unified biotech investment corridor.
> Listen on Spotify
> Listen on Apple Podcasts
> Listen on Amazon Music
> Watch on YouTube
In this episode of Denatured, you’ll listen to Christina Takke, managing partner at V-Bio Ventures and Mariette van der Velden-Roesink, founding partner at Curie Capital. We examine why Benelux delivers world‑class science yet remains an investment patchwork, and what it will take to knit the region into a truly unified biotech investment corridor.
Host
Jennifer C. Smith-Parker, Director of Insights, BioSpace
Guests
Christina Takke, Managing Partner, V-Bio Ventures
Mariette van der Velden-Roesink, Founding Partner, Curie Capital
Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.
